Literature DB >> 8358154

A comparative immunohistochemical study of phaeochromocytomas and paragangliomas.

M Fraga1, T García-Caballero, J Antúnez, M Couce, A Beiras, J Forteza.   

Abstract

There is no definite morphological distinction between phaeochromocytomas and paragangliomas. We, therefore, attempted to determine the universality and differential utility of a panel of tumour markers for diagnosis in formalin-fixed, paraffin-embedded specimens. Antibodies to neuron-specific enolase (NSE), chromogranin, synaptophysin, Leu-7, neurofilaments, cytokeratins, carcinoembryonic antigen (CEA), melanoma antigen HMB-45, S-100 protein and glial fibrillary acid protein (GFAP), were used on 11 phaeochromocytomas and 8 paragangliomas. NSE reactivity was detected in 10 phaeochromocytomas and in all paragangliomas. Chromogranin reactivity was found in all but two cases (one phaeochromocytoma and one paraganglioma). Synaptophysin reactivity was present in 10 phaeochromocytomas and in the 8 paragangliomas. Ten phaeochromocytomas stained for Leu-7, but none of the paragangliomas did. S-100-positive cells (sustentacular or type II cells) were found in 8 phaeochromocytomas and 7 paragangliomas. GFAP stained sustentacular cells of only one paraganglioma. Only in 5 phaeochromocytomas was there a focal reaction by neurofilaments. Cytokeratins, CEA and HMB-45 were never detected. We conclude that NSE, chromogranin, synaptophysin and S-100 protein are useful markers of both types of tumour, whereas GFAP staining is limited to a small number of these neoplasms. Leu-7 reactivity seems to favour diagnosis of phaeochromocytoma rather than paraganglioma, but further studies with larger series are needed to confirm this. Unlike previous reports, we did not find cytokeratin or HMB-45 immunostaining in any case.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8358154

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  5 in total

1.  Primary malignant melanoma of adrenal gland in a 41-yr-old woman.

Authors:  Attila Zalatnai; Béla Szende; Miklós Tóth; Károly Rácz
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

2.  Ultrastructure of pheochromocytoma: undescribed morphologic features.

Authors:  A Beiras Fernandez; A Kornberger; M Fraga; C F Vahl; A Beiras
Journal:  Virchows Arch       Date:  2017-04-20       Impact factor: 4.064

Review 3.  Molecular genetic alterations in adrenal and extra-adrenal pheochromocytomas and paragangliomas.

Authors:  Hilde Dannenberg; Paul Komminoth; Winand N M Dinjens; Ernst Jan M Speel; Ronald R de Krijger
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

Review 4.  Data set for the reporting of pheochromocytoma and paraganglioma: explanations and recommendations of the guidelines from the International Collaboration on Cancer Reporting.

Authors:  Lester D R Thompson; Anthony J Gill; Sylvia L Asa; Roderick J Clifton-Bligh; Ronald R de Krijger; Noriko Kimura; Paul Komminoth; Ernest E Lack; Jacques W M Lenders; Ricardo V Lloyd; Thomas G Papathomas; Peter M Sadow; Arthur S Tischler
Journal:  Hum Pathol       Date:  2020-05-11       Impact factor: 3.466

5.  Carotid Body Paraganglioma.

Authors:  Rashmi Maruti Hosalkar; Jayesh S Khivasara; Niharika Swain
Journal:  Ann Maxillofac Surg       Date:  2019 Jul-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.